Phibro Animal Health Corporation develops, manufactures, and supplies a range of animal health and mineral nutrition products for livestock primarily in the United States. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for a range of food animals, including poultry, swine, beef and dairy cattle, and aquaculture. Its animal health products also comprise antibacterials that are biological or chemical products used in the animal health industry to treat or to prevent bacterial diseases; anticoccidials primarily used to prevent and control the disease coccidiosis in poultry and cattle; anthelmintics to treat infestations of parasitic intestinal worms; and anti-bloat treatment products for cattle to control bloat in animals grazing on legume or wheat-pasture. In addition, the company offers nutritional specialty products, which enhance nutrition to help improve health and performance; and vaccines to prevent diseases primarily for the poultry and swine markets. Further, it manufactures and markets formulations and concentrations of trace minerals, such as zinc, manganese, copper, iron, and other compounds; and various specialty ingredients for use in the personal care, industrial chemical, and chemical catalyst industries. The company sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle integrators, as well as through commercial animal feed manufacturers, wholesalers, and distributors. It operates in the United States, Latin America, Canada, Europe, the Middle East, Africa, and the Asia Pacific. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation was incorporated in 2014 and is headquartered in Teaneck, New Jersey.

Phibro Animal Health Corporation

Lallemand Inc. specializes in the development, production, and marketing of microorganisms and their derivatives, offering microbiological solutions for various industries including health, nutrition, and food.

Lallemand Inc.

Paretos offers decision intelligence software that utilizes AI for forecasting and optimization, designed to enhance efficiency in business operations.

Paretos

Phibro Animal Health Corporation develops and markets products for animal health and nutrition.

Metric
Company Name	Phibro Animal Health Corporation	Lallemand Inc.	Paretos
Symbol	PAHC
MSH ID	COM:PAHC	COM:LALLEMAND	COM:PARETOS
Market	STOCKS	PRIVATE	PRIVATE
Sector	Healthcare	Consumer Goods	Technology
Industry	Drug Manufacturers - Specialty & Generic	Biotechnology	Software and AI
Country	US	CA	DE
Stage			Series A
Employee Count	1.92K
Website	pahc.com	lallemand.com	paretos.com
LinkedIn		lallemand	paretoscom
Founders

Metric
Market Cap	663.85M
Enterprise Value
Monthly Web Traffic		34.51K	1.37K
Web Traffic Growth		-0.50	-0.95
Valuation
Raised Capital			9.19M

Metric
Revenue	1.02B
Revenue (LTM)
Revenue (NTM)
Gross Profit	312.49M
EBITDA	98.60M
Operating Income	62.42M
Net Income	2.42M
EPS	0.06
Diluted EPS	0.06
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.31
Operating Profit Margin	0.06
EBITDA Margin	0.10
Net Profit Margin	0.02
Return on Equity	0.05
Return on Assets	0.02
Return on Capital Employed	0.07

COM:PAHC

Phibro Animal Health Corporation

Last Close

23.76

22/11 21:00

Market Cap

663.85M

Beta: -

Volume Today

132.86K

Avg: -

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	21.03
P/B Ratio	1.59
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	0.99
EV Multiple	7.27

Metric
Days Sales Outstanding	55.77
Days Payables Outstanding	41.49
Days Inventory Outstanding	153.11
Operating Cycle	209.10
Cash Conversion Cycle	163.40
Asset Turnover	1.04

Metric
Operating Cash Flow	87.59M
Free Cash Flow	46.36M
Cash Flow to Debt	0.23
Operating Cash Flow/Sales	0.09
Free Cash Flow Yield	0.01

Metric
Cash & Equivalents	70.61M
Accounts Receivable	-8.68M
Inventory	265.91M
Goodwill	54.56M
Debt to Capitalization	0.66
Debt to Assets	0.54
Current Ratio	3.39
Quick Ratio	1.67

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue	-0.01
R&D to Revenue
SG&A to Revenue